Article citationsMore>>

Stratton, I.M., Adler, A.I., Neil, H.A.W., Matthews, D.R., Manley, S.E., Cull, C.A., Hadden, D., Turner, R.C. and Holman, R.R. (2000) Association of Glycemia with Macrovascular and Microvascular Complications of Type 2 Diabetes (UKPDS 35): Prospective Observational Study. BMJ, 321, 405-412.
https://doi.org/10.1136/bmj.321.7258.405

has been cited by the following article:

• TITLE: Glycemic Control and Microvascular Complications of Type 2 Diabetes among Saudis

  AUTHORS: Fahad S. Al-Shehri

  KEYWORDS: Type 2 Diabetes, Glycemic Control, Microvascular Complications

  JOURNAL NAME: Journal of Diabetes Mellitus, Vol.9 No.4, November 18, 2019

  ABSTRACT: Objective: To study the relation between level of glycemic control and different micovascular complications of type 2 diabetes among Saudis. Patients and Methods: This hospital-based study analyzed the medical records of 343 type 2 diabetic patients attending the “University Diabetes Center” in “King Abdul-Aziz” University Hospital, in Riyadh City within 2006. Inclusion criteria comprised being adult, Saudi, type 2 diabetic, whose disease duration is more than one year, non-pregnant (for females). Results: Half of patients (50.4%) were not controlled (HbA1c > 8%). Vascular complications of diabetes were mainly retinopathy (45.8%) or neuropathy (32.7%). Prevalence of nephropathy was 9.9%. Patients’ sex, age, marital status and occupation were not significant variables as regard their control of diabetes. Patient’s educational status was significantly associated with degree of diabetes control; the higher the patient’s education the better the glycemic control (p = 0.002). Moreover, the longer the duration of diabetes, the worse the glycemic control (p Conclusions: Glycemic control among type 2 diabetics is a real challenge that should the health care team face in tertiary-care diabetes centers in KSA. Microvascular complications are common, especially among poorly controlled cases. Recommendations: The current goal for glycemic control at the University Diabetes Center (HbA1c